These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 30407498)

  • 21. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
    Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
    Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
    Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
    Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
    APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity.
    Dols JA; Molenaar D; van der Helm JJ; Caspers MP; de Kat Angelino-Bart A; Schuren FH; Speksnijder AG; Westerhoff HV; Richardus JH; Boon ME; Reid G; de Vries HJ; Kort R
    BMC Infect Dis; 2016 Apr; 16():180. PubMed ID: 27107961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
    Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
    PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.
    Thurman AR; Kimble T; Herold B; Mesquita PM; Fichorova RN; Dawood HY; Fashemi T; Chandra N; Rabe L; Cunningham TD; Anderson S; Schwartz J; Doncel G
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1139-52. PubMed ID: 26204200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Analysis on Recurrence of Bacterial Vaginosis Revealed Microbes and Clinical Variables Important for Treatment Outcome.
    Xiao B; Wu C; Song W; Niu X; Qin N; Liu Z; Xu Q
    Front Cell Infect Microbiol; 2019; 9():189. PubMed ID: 31245300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial.
    Armstrong E; Hemmerling A; Miller S; Burke KE; Newmann SJ; Morris SR; Reno H; Huibner S; Kulikova M; Nagelkerke N; Coburn B; Cohen CR; Kaul R
    Lancet Microbe; 2022 Jun; 3(6):e435-e442. PubMed ID: 35659905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vaginal microbiota in the course of bacterial vaginosis treatment.
    Zwittink RD; van den Munckhof EHA; Leverstein-van Hall MA; Boers K; Molijn A; Knetsch CW; Kuijper EJ
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):651-656. PubMed ID: 33029765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.
    Gustin AT; Thurman AR; Chandra N; Schifanella L; Alcaide M; Fichorova R; Doncel GF; Gale M; Klatt NR
    Am J Obstet Gynecol; 2022 Feb; 226(2):225.e1-225.e15. PubMed ID: 34560047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genital inflammation and the risk of HIV acquisition in women.
    Masson L; Passmore JA; Liebenberg LJ; Werner L; Baxter C; Arnold KB; Williamson C; Little F; Mansoor LE; Naranbhai V; Lauffenburger DA; Ronacher K; Walzl G; Garrett NJ; Williams BL; Couto-Rodriguez M; Hornig M; Lipkin WI; Grobler A; Abdool Karim Q; Abdool Karim SS
    Clin Infect Dis; 2015 Jul; 61(2):260-9. PubMed ID: 25900168
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Shvartsman E; Perciani CT; Richmond MEI; Russell JNH; Tough RH; Vancuren SJ; Hill JE; Kavi-Icr ; Jaoko W; McKinnon LR; Sandstrom PA; MacDonald KS
    Front Immunol; 2022; 13():974195. PubMed ID: 36726972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women.
    Tamrakar R; Yamada T; Furuta I; Cho K; Morikawa M; Yamada H; Sakuragi N; Minakami H
    BMC Infect Dis; 2007 Nov; 7():128. PubMed ID: 17986357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation.
    Bloom SM; Mafunda NA; Woolston BM; Hayward MR; Frempong JF; Abai AB; Xu J; Mitchell AJ; Westergaard X; Hussain FA; Xulu N; Dong M; Dong KL; Gumbi T; Ceasar FX; Rice JK; Choksi N; Ismail N; Ndung'u T; Ghebremichael MS; Relman DA; Balskus EP; Mitchell CM; Kwon DS
    Nat Microbiol; 2022 Mar; 7(3):434-450. PubMed ID: 35241796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic Evidence on the Role of Lactobacillus iners in Sexually Transmitted Infections and Bacterial Vaginosis: A Series of Systematic Reviews and Meta-Analyses.
    Carter KA; Fischer MD; Petrova MI; Balkus JE
    Sex Transm Dis; 2023 Apr; 50(4):224-235. PubMed ID: 36729966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
    Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
    Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.
    Plummer EL; Vodstrcil LA; Danielewski JA; Murray GL; Fairley CK; Garland SM; Hocking JS; Tabrizi SN; Bradshaw CS
    PLoS One; 2018; 13(1):e0190199. PubMed ID: 29293559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis.
    Spear GT; Sikaroodi M; Zariffard MR; Landay AL; French AL; Gillevet PM
    J Infect Dis; 2008 Oct; 198(8):1131-40. PubMed ID: 18717638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial colonization and beta defensins in the female genital tract in HIV infection.
    Jiang W; Ghosh SK; Flyckt R; Kalinowska M; Starks D; Jurevic R; Weinberg A; Lederman MM; Rodriguez B
    Curr HIV Res; 2012 Sep; 10(6):504-12. PubMed ID: 22716110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.
    Sha BE; Zariffard MR; Wang QJ; Chen HY; Bremer J; Cohen MH; Spear GT
    J Infect Dis; 2005 Jan; 191(1):25-32. PubMed ID: 15592999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.